Pfizer Can't Boot Doctors' Suicide Testimony From Chantix MDL

Law360, New York (August 24, 2012, 2:02 PM EDT) -- An Alabama federal judge on Tuesday mostly rejected Pfizer Inc.’s attempt to toss expert testimony in a multidistrict litigation alleging the company should have known its smoking cessation drug Chantix was linked to suicidal thoughts, saying the doctors’ testimonies were reliable.

Pfizer asked the court to toss out testimony from six doctors that touched on either the reasons Chantix allegedly causes depressive or suicidal symptoms, the method by which these side effects could occur, or whether Pfizer should have recognized the drug had the potential to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.